Figures S1-7 from CD30-Redirected Chimeric Antigen Receptor T Cells Target CD30&lt;sup&gt;+&lt;/sup&gt; and CD30&lt;sup&gt;−&lt;/sup&gt; Embryonal Carcinoma via Antigen-Dependent and Fas/FasL Interactions